Neovascularization, Pathologic
"Neovascularization, Pathologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
| Descriptor ID |
D009389
|
| MeSH Number(s) |
C23.550.589.500
|
| Concept/Terms |
Neovascularization, Pathologic- Neovascularization, Pathologic
- Pathologic Neovascularization
- Neovascularization, Pathological
- Pathological Neovascularization
- Pathologic Angiogenesis
- Angiogenesis, Pathologic
- Angiogenesis, Pathological
- Pathological Angiogenesis
|
Below are MeSH descriptors whose meaning is more general than "Neovascularization, Pathologic".
Below are MeSH descriptors whose meaning is more specific than "Neovascularization, Pathologic".
This graph shows the total number of publications written about "Neovascularization, Pathologic" by people in this website by year, and whether "Neovascularization, Pathologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2000 | 4 | 0 | 4 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 3 | 5 |
| 2003 | 3 | 1 | 4 |
| 2004 | 5 | 10 | 15 |
| 2005 | 8 | 5 | 13 |
| 2006 | 4 | 4 | 8 |
| 2007 | 4 | 8 | 12 |
| 2008 | 2 | 3 | 5 |
| 2009 | 6 | 5 | 11 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 2 | 4 |
| 2012 | 2 | 3 | 5 |
| 2013 | 4 | 2 | 6 |
| 2014 | 4 | 4 | 8 |
| 2015 | 4 | 3 | 7 |
| 2016 | 2 | 4 | 6 |
| 2017 | 3 | 2 | 5 |
| 2018 | 2 | 1 | 3 |
| 2019 | 4 | 0 | 4 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 3 | 3 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neovascularization, Pathologic" by people in Profiles.
-
HuR as a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliv Rev. 2022 09; 188:114442.
-
Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis. Angiogenesis. 2022 08; 25(3):397-410.
-
Chronic subdural hematoma recurrence due to contralateral neovascularization following middle meningeal artery embolization. Interv Neuroradiol. 2022 Dec; 28(6):639-643.
-
A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Deliv. 2021 Dec; 28(1):1432-1442.
-
Modulation of p75NTR on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model. Int J Mol Sci. 2021 Jan 15; 22(2).
-
Retinal Physiology and Circulation: Effect of Diabetes. Compr Physiol. 2020 07 08; 10(3):933-974.
-
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Ann Surg Oncol. 2019 Dec; 26(13):4782-4790.
-
Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Liver Transpl. 2019 08; 25(8):1155-1164.
-
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis. Anticancer Res. 2019 May; 39(5):2277-2287.
-
Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats. PLoS One. 2019; 14(1):e0210523.